Catinazzo Thomas 4
4 · Relay Therapeutics, Inc. · Filed Oct 30, 2024
Insider Transaction Report
Form 4
Catinazzo Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-10-28$6.06/sh−5,105$30,936→ 306,391 total - Sale
Common Stock
2024-10-28$6.06/sh−1,697$10,284→ 311,496 total - Sale
Common Stock
2024-10-29$5.95/sh−2,300$13,685→ 304,091 total
Footnotes (3)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,724 shares of restricted stock units ("RSUs") on October 27, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 292,490 shares underlying RSUs.
- [F3]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.